Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome

American Journal of the Medical Sciences

Volumn 321, Issue 4, 2001, Pages 225-236

  Alpert, Martin A ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

Cardiac morphology; Congestive heart failure; Hemodynamics; Left ventricular function; Obesity; Obesity hypoventilation syndrome; Sleep apnea

Indexed keywords

BLOOD VOLUME; BODY FAT; CARDIOMYOPATHY; CAUSE OF DEATH; CONFERENCE PAPER; DIASTOLE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEART VENTRICLE FUNCTION; HUMAN; HYPERTROPHY; HYPOVENTILATION; METABOLIC ACTIVATION; MORPHOLOGY; OBESITY; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME; SUDDEN DEATH;

EID: 0035064965     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200104000-00003     Document Type: Conference Paper

References (89)

1. Cardiac morphology and obesity in man
2. Hemodynamic alterations with obesity in man
3. Obesity and ventricular function in man: Diastolic function
4. Obesity and ventricular function in man: Systolic function
5. Pathogenesis and clinical manifestations of obesity cardiomyopathy
6. Historical notes
7. Adioposity of the heart
8. Fatty infiltration of myocardium
9. Myocardial fat infiltration
10. The cardiac pathology of obesity
11. Obesity and congestive heart failure
12. The heart in massive (more than 300 pounds or 136 kilograms) obesity. Analysis of 12 patients studied at necropsy
13. Cardiomyopathy of obesity. A clinical pathologic evaluation of 43 obese patients with heart failure
14. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity
15. Feasibility of detailed M-mode echocardiographic examination in markedly obese adults, Prospective study of 50 patients
16. Echocardiographic findings in obesity
17. Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects
18. Dimorphic cardiac adaptation to obesity and arterial hypertension
19. Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiomyopathy of obesity
20. Noninvasive study of left ventricular performance in obese patients: Influences of duration of obesity
21. Left ventricular filling in normotensive obese adults
22. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: Survey and intervention study
23. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The Framingham Heart Study
24. The impact of obesity on left ventricular mass and geometry. The Framingham Study
25. Ventricular mass in hypertensive and normotensive obese subjects
26. Relation between body fat distribution and left ventricular mass in men without structural heart disease or systemic hypertension
27. Interrelationship of left ventricular mass systolic function and diastolic filling in normotensive morbidly obese patients
28. Relationship of duration of morbid obesity to left ventricular mass, systolic function and diastolic filling and effect of weight loss
29. Insulin resistance is an important determinant of left ventricular mass in obese
30. Cardiac morphology and left ventricular function in morbidly obese patients with and without congestive heart failure and effect of weight loss
31. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
32. Effect of obesity on echocardiographic parameters in children
33. Effect of total adipose weight and systemic hypertension of left ventricular mass in children
34. Evaluation of the cardiovascular system in children with simple obesity: Part II echocardiographic assessment
35. Effect of lean body mass, fat mass, blood pressure and sexual maturation on left ventricular mass in children and adolescents
36. Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity
37. Obesity and cardiac function
38. Obesity and cardiac performance
39. Cardiovascular function in extreme obesity
40. Role of circulatory congestion in the cardiorespiratory failure of obesity
41. Hemodynamic and respiratory changes in surgery of the morbidly obese
42. Borderline hypertension and obesity: Two pre-hypertensive states with elevated cardiac ouput
43. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion and plasma renin activity
44. Relation of central hemodynamics to obesity and body fat distribution
45. Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity. Relationship with central hemodynamic and left ventricular function
46. Cerebral hemodynamics and oxygen utilization in extreme obesity
47. The nitrous oxide method for the quantitative determination of CBF in man. Theory, procedure and normal values
48. Estimation of hepatic blood flow in man
49. Measurement of blood flow in adipose tissue from the washout of xenon-133 after atraumatic labeling
50. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity
51. Left ventricular filling in the systemic hypertension of obesity
52. Effects of obesity and weight loss on cardiac function and valvular performance
53. The influence of obesity on left ventricular filling and systolic function
54. Body fat distribution and left ventricular morphology and function in obese females
55. Left ventricular filling abnormalities in asymptomatic morbid obesity
56. Left ventricular diastolic and systolic function in normotensive obese subjects. Influence of degree and duration of obesity
57. Effect of weight loss on left ventricular diastolic filling in obesity
58. Disparate cardiovascular effects of obesity and arterial hypertension
59. Obesity, pregnancy and left ventricular function during the third trimester
60. Factors influencing left ventricular systolic function in non-hypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty
61. Hemostatic function in young subjects with central obesity. Relationship with left ventricular function
62. Left ventricular function response to exercise in normotensive obese subjects: Influence of degree and duration of obesity
63. Effect of exercise on left ventricular function and reserve in morbid obesity
64. Assessment of cardiac function in patients who were morbidly obese
65. Effect of exercise and cavity size on right ventricular function in morbid obesity
66. Obesity and the heart
67. The cardiomyopathy of obesity
68. Obeservations on some clinical features of extreme obesity, with particular reference to cardiorespiratory effects
69. Heart failure from obesity
70. A peculiar type of cardiopulmonary failure associated with obesity
71. De subitaneis mortibus III. Pickwickian syndrome
72. Reversible cardiopulmonary syndrome with extreme obesity
73. Cardiorespiratory syndrome of extreme obesity with papilledema
74. Serious complications and death in the Pickwickian syndrome
75. The electrocardiogram and cardiac anatomy in obesity
76. The electrocardiogram in obesity
77. The echocardiogram in morbid obesity
78. A study of the tranverse diameter of the heart silhouette with prediction based on the teleoroentgenogram
79. Value and limitations of echocardiography in the evaluation of obese patients
80. Heart failure due to extreme obesity
81. Cardiorespiratory syndrome of obesity in a child
82. Cardiac pathology in the sudden death of an extremely obese person
83. Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy
84. Sudden death as a result of heart disease in morbid obesity
85. Overweight and sudden death. Increased ventricular ectopy in cardiomyopathy of obesity
86. Cardiac conduction system involvement in sudden death of obese young people
87. Heart block caused by fat infiltration of the interventricular septum "cor adiposum."
88. Fat infiltration of myocardium as a cause of cardiac conduction defect
89. Sudden death, hypertension and hypertrophy